Joseph J. Ricotta, M.D.
Special Expertise: Vascular Surgery
Undergraduate: Yale University
Medical School: Jefferson Medical College
Internship: Johns Hopkins School of Medicine—General Surgery
Residency: Johns Hopkins School of Medicine—General Surgery (Chief Resident), Oxford University School of Medicine, Oxford—General and Vascular Surgery
Fellowship: Mayo Clinic College of Medicine—Vascular and Endovascular Surgery, Cleveland Clinic Foundation—Advanced Endovascular Surgery
It has been another year of firsts for Joseph J. Ricotta, M.D., M.S., DFSVS, FACS, and his team at Prime Vascular Institute in Delray Beach. He performed his 375th TCAR operation earlier this year. They’re the first in Florida to develop a pulmonary embolism program using artificial intelligence (AI) to help save lives, and people from around the country have come to them for their life and limb-saving procedures. Prime Vascular’s 24,000-square foot facility will expand this year, offering more advanced, state-of-the-art diagnosis and treatment options. “We can provide comprehensive treatment to a patient, tailored to their specific needs, so they don’t need to go anywhere else.”
Dr. Ricotta and his team are at the top of their field and one of the most experienced when it comes to TCAR. “We’re recognized nationally for our extensive experience and excellent patient outcomes. We’ve helped shape the field and push the technology forward.” TCAR (transcarotid artery revascularization) reverses blood flow away from the brain while the physician repairs the blockage in the carotid artery to prevent stroke.
In addition to being the first in the U.S. to use endovascular robotics to perform minimally invasive vascular surgery, Dr. Ricotta is the first in Florida to operate on a patient using the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System which is designed to prevent aortic aneurysms from growing and can allow patients to avoid future surgery for aneurysm repair or rupture.
Dr. Ricotta also specializes in preventing leg amputations. Through his diligent practice, the amputation rate has decreased from 17% to less than 1%. “Amputation and survival rates are correlated,” he says. “Once you have a limb amputated, your mortality rate goes up. By saving a limb, we save a life and preserve quality of life.”
Dr. Ricotta is the National Director for Vascular Surgery and Endovascular Therapy for Dallas-based Tenet Healthcare and chairman of the Department of Vascular Surgery at Delray Medical Center. He founded and directs the FAU Vascular Surgery Fellowship and is a professor of surgery at FAU School of Medicine dedicated to training the country’s future vascular surgeons. He has authored more than 300 publications and delivered more than 500 lectures on the national and international stage.
Location: 16215 S. Jog Road, Ste. 100, Delray Beach, 561-303-0013, primevascular.com
Castle Connolly Top Docs 2024 Special Advertising Section